Clinical Trial Update: Bioenergetic Effect of Pioglitazone in CLD-PH [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the bioenergetic effects of pioglitazone in pulmonary hypertension associated with chronic lung disease is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Pulmonary Hypertension Due to Lung Diseases

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Emory University | Conditions: Pulmonary Hypertension, Pulmonary Hypertension Due to Lung Diseases | Phase 2 | Status: RECRUITING